Clinical Trial: Phase 1/2 Clinical Study of HY07121 for Injection (Subcutaneous) in Patients With Advanced Solid Tumors

U.S., Aug. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07789327) titled 'Phase 1/2 Clinical Study of HY07121 for Injection (Subcutaneous) in Patients With Advanced Solid Tumors' on Aug. 24.

Brief Summary: This is a multi-center, open-label, phase 1/2 study to evaluate the safety, efficacy, and pharmacokinetic (PK)/pharmacodynamic (PD) characteristics of HY07121 for Injection (Subcutaneous) in participants with advanced solid tumors.

Study Start Date: Sept. 08

Study Type: INTERVENTIONAL

Condition: Safety Tolerability Efficacy

Intervention: DRUG: Test Product HY07121 for Injection (Subcutaneous)

Dosage form: Powder for solution for infusion. Strength: 10 mg/vial. Method of administration: Subcutaneo...